TENAX THERAPEUTICS, INC. Partners' Capital Account, Units, Sold in Private Placement
TENAX THERAPEUTICS, INC. (TENX) reported Partners' Capital Account, Units, Sold in Private Placement of 4.77 million shares for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-15.
Discontinued
us-gaap:PartnersCapitalAccountUnitsSoldInPrivatePlacement · last filed 2021-11-15
- TENAX THERAPEUTICS, INC. partners' capital account, units, sold in private placement for the quarter ending 2021-09-30 was 0.00 shares.
| Period end | Partners' Capital Account, Units, Sold in Private Placement 3 month | Partners' Capital Account, Units, Sold in Private Placement 6 month | Partners' Capital Account, Units, Sold in Private Placement 9 month |
|---|---|---|---|
| 2021-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | 4.77M shares 10-Q · filed 2021-11-15 | |
| 2021-06-30 | 4.77M shares 10-Q · filed 2021-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |